Cargando…
Combining Gold Nanoparticles with Other Radiosensitizing Agents for Unlocking the Full Potential of Cancer Radiotherapy
About half of cancer patients (50%) receive radiotherapy (RT) for the treatment of local tumors. However, one of the main obstacles in RT is the close proximity of adjacent organs at risk, resulting in treatment doses being limited by significant tissue toxicity, hence preventing the necessary dose...
Autores principales: | Alhussan, Abdulaziz, Bozdoğan, Ece Pinar Demirci, Chithrani, Devika B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064393/ https://www.ncbi.nlm.nih.gov/pubmed/33805917 http://dx.doi.org/10.3390/pharmaceutics13040442 |
Ejemplares similares
-
Utilizing Gold Nanoparticles as Prospective Radiosensitizers in 3D Radioresistant Pancreatic Co-Culture Model
por: Alhussan, Abdulaziz, et al.
Publicado: (2023) -
Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin
por: Han, Ocean, et al.
Publicado: (2022) -
Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment
por: Bromma, Kyle, et al.
Publicado: (2021) -
Investigation of Nano-Bio Interactions within a Pancreatic Tumor Microenvironment for the Advancement of Nanomedicine in Cancer Treatment
por: Alhussan, Abdulaziz, et al.
Publicado: (2021) -
Lipid-Nanoparticle-Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Nanoparticles in the Treatment of Pancreatic Cancer
por: Alhussan, Abdulaziz, et al.
Publicado: (2022)